FDA.reportPublic FDA data

sugammadex

Product NDC
72266-269
11-digit product format
722660269
Labeler code
72266
Product ID
72266-269_582676d1-997d-1623-e063-6294a90a7226
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
sugammadex
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Fosun Pharma USA Inc.
Application
ANDA214364
Marketing category
ANDA
Marketing start
2026-07-29
Substance
SUGAMMADEX SODIUM
Active strength
500 mg/5mL
Pharmacologic classes
gamma-Cyclodextrins [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A214364-001SUGAMMADEX SODIUMSUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-28
A214364-002SUGAMMADEX SODIUMSUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A214364-001AP
A214364-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A214364-001SUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-2884e616aacf4f…
2026-09-14 22:38:342026-08A214364-002SUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-2884e616aacf4f…
2026-08-18 06:07:402026-07A214364-001SUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-28caaa826d4ba7…
2026-08-18 06:07:402026-07A214364-002SUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-07-28caaa826d4ba7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A214364-001AP184e616aacf4f…
2026-09-14 22:38:342026-08A214364-002AP184e616aacf4f…
2026-08-18 06:07:402026-07A214364-001AP1caaa826d4ba7…
2026-08-18 06:07:402026-07A214364-002AP1caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
sugammadex
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SUGAMMADEX SODIUM500 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
ERJ6X2MXV7Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1726992Internal RxNorm lookup
1727000Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4f1c7cf8-3db7-3f92-e063-6394a90aece9Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
sugammadexSUGAMMADEXGland Pharma Limitedc61ee55a-e61b-4d3c-9ebc-cbf57290e36c2026-07-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 214364
application number: ANDA214364
sugammadexSUGAMMADEXGLENMARK PHARMACEUTICALS INC., USAe7897fc1-4553-460c-a29b-0bc91cd9ca102026-07-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 214364
application number: ANDA214364
sugammadexSUGAMMADEXFosun Pharma USA Inc.4f1c7cf8-3db7-3f92-e063-6394a90aece92026-04-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 214364
application number: ANDA214364
ndc (product): 72266-269

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
72266-269-107226602691010 VIAL, SINGLE-DOSE in 1 CARTON (72266-269-10) / 5 mL in 1 VIAL, SINGLE-DOSE (72266-269-01) 2026-07-29NoNoCurrent